Ads
related to: chlorthalidone indication for prostate cancer risk by psa level 3 7- Patient Story Videos
Watch Real Stories Of Patients
Who Have Battled Prostate Cancer.
- Cancer Progression
Understand The Different Kinds Of
Prostate Cancer & Its Progression.
- Support Your Loved Ones
Explore Resources And Get Guidance
On How To Care For Someone With PC.
- Understand Your Results
Learn About Tests And Scans Used
To Diagnose And Monitor PC.
- Patient Story Videos
perfectfaqs.com has been visited by 100K+ users in the past month
Search results
Results from the WOW.Com Content Network
The risk of disease progression and metastasis (spread of the cancer) may be increased, but this increase risk appears to be small if the program of surveillance is followed closely, generally including serial PSA assessments and repeat prostate biopsies every 1–2 years depending on the PSA trends.
[2] [3] [6] Other adverse effects may include gout, low blood magnesium, high blood calcium, allergic reactions, and low blood pressure. [2] [3] [7] Some reviews have found chlortalidone and hydrochlorothiazide to have a similar risk of adverse effects, [8] [9] while other reviews have found chlortalidone to have a higher risk.
Prostate cancer staging is the process by which physicians categorize the risk of cancer having spread beyond the prostate, or equivalently, the probability of being cured with local therapies such as surgery or radiation. Once patients are placed in prognostic categories, this information can contribute to the selection of an optimal approach ...
Men without prostate cancer typically have PSA levels of under 4 nanograms per milliliter (ng/mL), according to the American Cancer Society. PSA levels between 4 and 10 suggest you could have ...
The Gleason grading system is used to help evaluate the prognosis of men with prostate cancer using samples from a prostate biopsy. Together with other parameters, it is incorporated into a strategy of prostate cancer staging which predicts prognosis and helps guide therapy. A Gleason score is given to prostate cancer based upon its microscopic ...
The reduction in testosterone levels that occurs during GnRH antagonist therapy subsequently reduces the size of the prostate cancer. This in turn results in a reduction in prostate-specific antigen (PSA) levels in the patient's blood and so measuring PSA levels is a way to monitor how patients with prostate cancer are responding to treatment ...
Ads
related to: chlorthalidone indication for prostate cancer risk by psa level 3 7perfectfaqs.com has been visited by 100K+ users in the past month